← Back
$WGS All transactions

GeneDx Holdings Corp.

▼ SELL 10b5-1 Plan

$ Value

$299K

Shares

3,220

Price

$93

Filed

Jul 11

Insider

Name

Stueland Katherine

Title

Chief Executive Officer

CIK

0001689575

Roles

Director Officer

Transaction Details

Transaction Date

2025-07-09

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,720

Footnotes

The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. | Following the reported sales, in addition to the 1,720 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 473,709 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms.

Filing Info

Accession No.

0001415889-25-019666

Form Type

4

Issuer CIK

0001818331

Stueland Katherine's History

Date Ticker Type Value
2026-03-26 WGS M $0
2026-03-26 WGS $811K
2026-03-26 WGS $319K
2026-03-26 WGS $849K
2026-03-26 WGS $342K
2026-03-26 WGS $645K
2026-03-26 WGS M $0
2026-01-29 WGS M $0
2026-01-29 WGS $155K
2026-01-29 WGS M $0

Other Insiders at WGS (90d)

Insider Bought Sold Last
Stueland Katherine
CHIEF EXECUTIVE OFFICER
$3.1M 2026-03-26
Feeley Kevin
CHIEF FINANCIAL OFFICER
$587K 2026-03-26
Dechairo Bryan
Chief Operating Officer
$851K 2026-02-04